MiMe-A video!
Discover now the interview of Dr. Laura Polastro, Study Chair and Principal Investigator at Jules Bordet Institute, to find out about the scientific rationale behind
Accelerating treatment individualization, promoting multidisciplinarity and challenging current practices
Developing early to later phases based on cutting-edge designs
Building a strong collaboration between clinicians, scientists and stakeholders of clinical research
Discover now the interview of Dr. Laura Polastro, Study Chair and Principal Investigator at Jules Bordet Institute, to find out about the scientific rationale behind
Follow us on our Oncodistinct twitter account: @oncodistinct. We will keep you informed about Oncodistinct studies as well as other studies in the field of
ONCODISTINCT. Accelerating Oncology drug Development and Innovative strategies in Clinical Trials
© Oncodictinct 2024 – Privacy policy